The varicose vein treatment market in North America and Europe is expected to reach USD 289.7 million by 2021 from USD 207.9 million in 2016, at a CAGR of 6.9% between 2016 and 2021. North America is expected to hold the largest share of the varicose vein treatment market in 2016. The varicose vein treatment market is broadly segmented into mode of treatment and products. By products, the varicose vein treatment market is segmented into ablation devices, venous closure products, and surgical products. The ablation devices segment is further categorized into radio frequency ablation devices and laser ablation devices. In 2016, the radio frequency ablation devices segment is expected to command the major share of the ablation devices market for varicose vein treatment.
Geographically, the report covers two major geographies, namely, North America and Europe. In this report, the North American varicose vein treatment market is further segmented into the U.S. and Canada, while the European varicose vein treatment market is categorized into Germany, U.K., France, Italy, Spain, and Rest of Europe. In 2016, North America is expected to command the largest share of the varicose vein treatment market in North America and Europe. However, Europe is expected to register the highest growth rate during the forecast period from 2016 to 2021, due to increasing adoption of advanced treatment procedures and favorable government initiatives in this region.
Market growth is majorly driven by the shift towards less-invasive treatment procedures, availability of advanced varicose vein treatment devices, huge burden of varicose vein cases in North America and Europe, improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population.
As of 2015, the varicose vein treatment market was dominated by Medtronic plc (Ireland); Angio Dynamics, Inc. (U.S.); and biolitec AG (Austria) which together held a share of over 85% of the varicose vein treatment market. New product launches, strategic acquisitions, and agreements are the major strategies adopted by most market players to achieve growth in the varicose vein treatment market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis —market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the varicose vein treatment market, high-growth regions and their respective drivers, restraints, challenges, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, and competitive assessment) for strengthening their market share.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on varicose vein treatment products offered by the top 5 players in the varicose vein treatment market. The report analyzes the varicose vein treatment market by mode of treatment and products
- Product Development/Innovation: Detailed insights on current and upcoming technologies, research and development activities, product enhancements, and new product launches in the varicose vein treatment market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various varicose vein treatment devices across North America and Europe
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the varicose vein treatment market.